Literature DB >> 17673067

Diagnosis of interstitial lung diseases.

Jay H Ryu1, Craig E Daniels, Thomas E Hartman, Eunhee S Yi.   

Abstract

Interstitial lung diseases (ILDs), a broad heterogeneous group of parenchymal lung disorders, can be classified into those with known and unknown causes. The definitions and diagnostic criteria for several major forms of ILDs have been revised in recent years. Although well over 100 distinct entities of ILDs are recognized, a limited number of disorders, including idiopathic pulmonary fibrosis, sarcoidosis, and connective tissue disease-related ILDs, account for most ILDs encountered clinically. In evaluating patients with suspected ILD, the clinician should confirm the presence of the disease and then try to determine its underlying cause or recognized clinicopathologic syndrome. Clues from the medical history along with the clinical context and radiologic findings provide the initial basis for prioritizing diagnostic possibilities for a patient with ILD. High-resolution computed tomography of the chest has become an invaluable tool in the diagnostic process. A confident diagnosis can sometimes be made on the basis of high-resolution computed tomography and clinical context. Serologic testing can be helpful in selected cases. Histopathologic findings procured through bronchoscopic or surgical lung biopsy are often needed in deriving a specific diagnosis. An accurate prognosis and optimal treatment strategy for patients with ILDs depend on an accurate diagnosis, one guided by recent advances in our understanding of the causes and pathogenetic mechanisms of ILDs.

Entities:  

Mesh:

Year:  2007        PMID: 17673067     DOI: 10.4065/82.8.976

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  25 in total

1.  Acoustic thoracic image of crackle sounds using linear and nonlinear processing techniques.

Authors:  Sonia Charleston-Villalobos; Guadalupe Dorantes-Méndez; Ramón González-Camarena; Georgina Chi-Lem; José G Carrillo; Tomás Aljama-Corrales
Journal:  Med Biol Eng Comput       Date:  2010-07-21       Impact factor: 2.602

2.  Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosis.

Authors:  Sergio Harari; Olga Torre; Roberto Cassandro; Angelo M Taveira-DaSilva; Joel Moss
Journal:  Respir Med       Date:  2012-07-07       Impact factor: 3.415

3.  Aggregate risk score for predicting mortality after surgical biopsy for interstitial lung disease.

Authors:  Juan J Fibla; Alessandro Brunelli; Stephen D Cassivi; Claude Deschamps
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-05-17

4.  Evaluation of hemodynamic changes by use of phase-contrast MRI for patients with interstitial pneumonia, with special focus on blood flow reduction after breath-holding and bronchopulmonary shunt flow.

Authors:  Nanae Tsuchiya; Yuichiro Ayukawa; Sadayuki Murayama
Journal:  Jpn J Radiol       Date:  2012-12-20       Impact factor: 2.374

5.  Outcome Measures for Clinical Trials in Interstitial Lung Diseases.

Authors:  Matthew R Lammi; Robert P Baughman; Surinder S Birring; Anne-Marie Russell; Jay H Ryu; Marybeth Scholand; Oliver Distler; Daphne LeSage; Catherine Sarver; Katerina Antoniou; Kristin B Highland; Otylia Kowal-Bielecka; Joseph A Lasky; Athol U Wells; Lesley Ann Saketkoo
Journal:  Curr Respir Med Rev       Date:  2015

6.  Idiopathic pulmonary fibrosis: past, present, future-a review from Talmadge King's ATS 2016 presentation.

Authors:  S Clark Berngard; Kamyar Afshar
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

7.  Microbiology specimens obtained at the time of surgical lung biopsy for interstitial lung disease: clinical yield and cost analysis.

Authors:  Juan J Fibla; Alessandro Brunelli; Mark S Allen; Dennis Wigle; Robert Shen; Francis Nichols; Claude Deschamps; Stephen D Cassivi
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

8.  Influence of interstitial lung disease on outcome in systemic sclerosis: a population-based historical cohort study.

Authors:  Philippe R Bauer; Dante N Schiavo; Thomas G Osborn; David L Levin; Jennifer St Sauver; Andrew C Hanson; Darrell R Schroeder; Jay H Ryu
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

Review 9.  Clinical use of biomarkers of survival in pulmonary fibrosis.

Authors:  Michiel Thomeer; Jan C Grutters; Wim A Wuyts; Stijn Willems; Maurits G Demedts
Journal:  Respir Res       Date:  2010-06-28

10.  [Diagnosis and differential diagnosis of granulomatous myositis].

Authors:  H-J Gdynia; H Mogel; P Kühnlein; J Dorst; N Osterfeld; C A von Arnim; A-D Sperfeld
Journal:  Nervenarzt       Date:  2008-04       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.